Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.27 +0.07 (+2.95%)
As of: Oct 22, 2026 · 9:53 AM EDT

Rocket Pharmaceuticals (RCKT) Tax Provisions (2026)

Updated

Rocket Pharmaceuticals (RCKT) reported Tax Provisions of $8.62 million for Q2 2026.

Analysis

Rocket Pharmaceuticals (RCKT) Tax Provisions (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Eli Lilly 1,160.65 Bn 1,129.23 Bn 19.71 Bn 2.15 Bn
2 Johnson & Johnson 633.19 Bn 551.72 Bn 17.26 Bn 1.21 Bn
3 AbbVie 501.90 Bn 475.01 Bn 12.70 Bn 662.00 Mn
4 Merck 377.07 Bn 331.45 Bn 12.21 Bn 654.00 Mn
5 Novartis Ag 302.35 Bn 266.34 Bn 11.24 Bn 1.01 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 291.00 Mn
7 Amgen 240.68 Bn 196.07 Bn 7.24 Bn 393.00 Mn
8 Gilead Sciences 193.20 Bn 167.40 Bn 6.22 Bn 242.00 Mn
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn -407.00 Mn
10 Rocket Pharmaceuticals 254.47 Mn -29.23 Mn - 8.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.62 Mn
API Access

Rocket Pharmaceuticals Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=RCKT&period=max&api_key=YOUR_API_KEY